USE CASE #6
Increase your scientific share of voice and deepen relationships with HCPs
Drive the adoption of medical communication messaging
Summarised medical content plays a vital role in maintaining and gaining scientific share of voice for pharma companies and generating engagement data that can be fed back into message refinement and personalisation. See case study below:
Introduction
Increasing share of voice means driving, facilitating and encouraging conversations around product or therapeutic area. Exploring (and measuring) such reach reveals what HCPs think about products and research, where and what types of conversations are taking place among different stakeholders, and where educational gaps exist. Strategies to increase share of voice heavily rely on content. This is particularly true for scientific activities associated with medical affairs: publications, congresses and presentations, clinical studies, HCP education campaigns. Faced with a highly competitive market in a specific therapy area, pharma companies reach out to SciencePOD for content solutions that help boost share of voice among HCPs.
Highlights
Problem
| • Positioning of innovative medicines with higher patient benefits among competitors |
| • Retention of therapy as preferred solution among HCPs. |
SciencePOD solution
Planning and delivery of summarised evidence-based digital content designed to effectively boost adoption and internalisation of key messages, delivered consistently through a 12-month programme. Summarised content applies storytelling techniques that help reinforce messaging and retention.
Summary
SciencePOD is a specialist creator of summarised medical and evidence-based content derived from complex studies and data, including scientific and medical publications, medical congresses presentations, and clinical studies. The consistent delivery of this summarised content (and the continued refinement of key messaging) allows pharma companies to successfully implement strategies to increase share of voice among HCPs.